Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences

Launched by POWER LIFE SCIENCES INC. · Apr 6, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the experiences of patients with anaplastic thyroid cancer when it comes to participating in clinical research studies. The researchers want to learn about the challenges and barriers that may prevent patients from joining these studies and why some individuals might choose to withdraw or stop participating. By identifying these factors, the goal is to improve future clinical research opportunities for people with anaplastic thyroid cancer.

To be eligible for this trial, participants must have a confirmed diagnosis of anaplastic thyroid cancer and be willing to follow all study procedures. They need to be able to provide informed consent, meaning they understand the study and agree to participate. Unfortunately, those who do not have a diagnosis of anaplastic thyroid cancer, have serious medical conditions, or are pregnant or breastfeeding cannot join. The trial is currently not recruiting participants, but the insights gained will help enhance the experience of future patients who may be invited to take part in similar studies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with anaplastic thyroid cancer
• • Willing to comply with all study related procedures and assessments
• • Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol
• Exclusion Criteria:
• • No documented diagnosis of anaplastic thyroid cancer
• • Any serious and/or unstable pre-existing medical disorders
• • Pregnant or lactating woman